The Health Threat Posed by the Hidden Epidemic of Anabolic Steroid Use and Body Image Disorders Among Young Men

Author:

Goldman Anna L12ORCID,Pope Harrison G23ORCID,Bhasin Shalender124ORCID

Affiliation:

1. Research Program in Men's Health: Aging and Metabolism, Brigham and Women’s Hospital, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts

3. Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts

4. Boston Claude D. Pepper Older Americans Independence Center, Boston, Massachusetts

Abstract

Abstract Context The prevalence of body image disorders and anabolic-androgenic steroid (AAS) use is increasing, despite the evidence of their serious adverse health effects and despite the passage of laws regulating their sales. Here we review the evolution of the dual emerging epidemics of body image disorders and AAS use, adverse health effects of AASs, and the need for an integrated health policy and regulatory response. Evidence Acquisition We searched for studies published prior to June 2018. Quality of evidence was low to moderate because of its observational nature; heterogeneity of eligibility criteria; variable doses; reliance on retrospective self-reported data in many studies; and variable quality of outcome ascertainment. Evidence Synthesis Most AAS users are nonathlete young men, who use these substances to look lean and more muscular. Some of these men suffer from “muscle dysmorphia,” a form of body dysmorphic disorder. AASs has been associated with cardiovascular disorders, psychiatric disorders, AAS-withdrawal hypogonadism, infertility, neurotoxic effects, musculoskeletal injuries, liver toxicity, and needle-borne infections. Potential adverse effects may be compounded by the use of other substances (e.g., opioids) and high-risk behaviors. Unregulated Internet sales of AASs and selective androgen receptor modulators, which are easily purchased without a prescription, are of concern because of their potential to fuel the epidemic among adolescents and the military. Conclusions Integrated nationwide efforts are necessary to raise public awareness of this epidemic, to study long-term health effects of AASs and treatment strategies, and to reform regulations to stem the epidemics of AAS use and body image disorders.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. 21 U.S.C. 802—DEA Diversion Control Division—Department of Justice. Available at: www.deadiversion.usdoj.gov/21cfr/21usc/802.htm. Accessed 15 October 2018.

2. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging;Bhasin;Nat Clin Pract Endocrinol Metab,2006

3. Selective androgen receptor modulators in preclinical and clinical development;Narayanan;Nucl Recept Signal,2008

4. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement;Pope;Endocr Rev,2014

5. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis;Sagoe;Ann Epidemiol,2014

Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3